Concord Biotech Limited Latest Share Price, Insights and Trends

Concord Biotech Limited is an Indian biopharma company headquartered in Ahmedabad, Gujarat. It is an R&D driven company that specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and finished formulations.

Key Aspects of Concord Biotech Limited:

R&D Driven: Concord Biotech focuses on developing and manufacturing complex pharmaceutical products through fermentation and semi-synthetic processes. They have a dedicated R&D facility recognized by the Department of Science & Industrial Research (DSIR), India.

Products: They offer a wide range of APIs and finished formulations in various therapeutic segments, including:
Immunosuppressants
Anti-infectives (antibacterial, antifungal, anthelmintic)
Oncology
Nephrology & Critical Care

Manufacturing Facilities: Concord Biotech has three manufacturing facilities in Gujarat, India, dedicated to API production (Dholka and Limbasi) and formulation production (Valthera). These facilities are equipped with advanced technology and adhere to international quality standards, including USFDA and EUGMP approvals.

Global Presence: Concord Biotech has a global presence and supplies its products to more than 70 countries worldwide, including the USA and Europe.

Contract Research & Manufacturing (CRAM): They also offer CRAM services, leveraging their expertise in biotechnology and chemistry to assist other pharmaceutical companies with product development and manufacturing.

Financial Performance: The company has demonstrated healthy financial growth, with increasing revenues and net profits in recent years. They have also reduced their debt and maintained a healthy dividend payout.

Recent Developments:

Received USFDA Establishment Inspection Report (EIR) for their Dholka API facility, confirming compliance with regulatory standards.

Commissioned a new injectable manufacturing facility at Valthera, expanding their capabilities in complex formulations.

Reported strong Q4 FY25 results with increased revenue and net profit.

In essence, Concord Biotech is a prominent player in the biopharmaceutical industry, focusing on research, development, and manufacturing of a diverse range of APIs and formulations, with a strong global reach.
.
* About Concord Biotech Limited information is from various sources on the internet.
( March 2024 ).
Please verify the official website of Concord Biotech Limited for the latest updated information.

Please visit
https://investinstocks.co.in/find-any-stock-of-Indian-stock-market/
to know about any company.

.

What’s your view on this stock? Please comment.

*Data is only for info. Not Buy or Sell advice.
*** Don’t waste your hard earned money by trading in stock market.
Don’t trade.
100% of the traders will loose money in the market.
“Invest in stock market.”
Consult financial expert before investing.
.

Results Declared Stocks 2025 Dec